Loading…
← CockpitCompetitor Analysis › 603990.SS Suzhou MedicalSystem Technology Co., Ltd. Class AOpen in the cockpit ↗

Suzhou MedicalSystem Technology Co., Ltd. Class A603990.SSCompetitor analysis, valuation and peers

China · CNY·Information Technology›Packaged Software
Momentum leader 95
Mkt cap
$991M
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$78.0M
20-day average traded
Fwd P/E
90.9×
forward earnings
ROIC−WACC
-6.0 pp
WACC 8.0%
Hurdle
n/a
no reverse DCF
Next earnings
159 days
26 Apr 2027
Close · CNYCN¥21.20
1D-5.1%
1W-13.7%
1M+5.0%
3M-4.8%
6M+28.0%
YTD+39.8%
1Y+27.6%
ATR %6.3%
52w lowhigh16.6% off high

What Suzhou MedicalSystem Technology does

Employees: 632

Suzhou MedicalSystem Technology at a glance

Size Suzhou MedicalSystem Technology (603990.SS) is a China Information Technology company (Packaged Software) with a market value of $991M, the 2175th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥21.20 on 18 Nov 2026.

Performance Over six months the shares gained 28.0%, against -17.3% for the median peer and -20.0% for the China market (cap-weighted) — 3rd highest of 18 in its peer set.

Growth Revenue fell 15.0% over the last twelve months (peer median +12.3%); the operating margin is 5.5% (peer median 5.2%).

Valuation It trades at 90.9× forward earnings against a peer median of 19.6× (2nd most expensive of 13).

Capital Return on invested capital runs 6.0 points below its cost of capital (8.0% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

7510012515021 May 202621 Aug 202618 Nov 2026603990.SS 129Peer median 83
Six months, rebased to 100: Suzhou MedicalSystem Technology against the median of its 20 peers (local-currency closes).

Suzhou MedicalSystem Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥289MCN¥300MCN¥462MCN¥615MCN¥303M
Revenue growth—-35%-25%+103%—
Gross profitCN¥146MCN¥159MCN¥37.9MCN¥101MCN¥204M
EBITDACN¥52.8MCN¥48.9M-CN¥154M-CN¥198MCN¥37.5M
Net incomeCN¥17.5MCN¥39.2M-CN¥279M-CN¥269MCN¥33.6M
Free cash flowCN¥33.8M-CN¥2.21M-CN¥261M-CN¥907MCN¥33.4M
Capital expenditureCN¥37.3MCN¥68.6MCN¥252MCN¥600MCN¥24.6M
Total debtCN¥231MCN¥276MCN¥426MCN¥1.86BCN¥163M

Quarterly statements and history in the cockpit →

Suzhou MedicalSystem Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-20%0%+20%BVS6636PLTKFQT002605BLACKBUCK300467239160308230034874SWPAR293490EVCM3008720354603990.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Suzhou MedicalSystem Technology is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×100×200×300×BVS6636PLTKFQT002605BLACKBUCK30034874SWPAR300872603990.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Suzhou MedicalSystem Technology is the large dot.

Suzhou MedicalSystem Technology competitors and peer comparison

How Suzhou MedicalSystem Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Suzhou MedicalSystem Technology against its 20 peers (data as of 18 Nov 2026)
Measure603990.SSPeer medianRank in peer set
1-month return+5.0%-6.0%7th highest of 21
6-month return+28.0%-17.3%3rd highest of 18
Distance from 52-week high-16.6%-42.6%2nd highest of 21
Revenue growth (TTM)-15.0%+12.3%2nd lowest of 21
Operating margin5.5%5.2%11th highest of 21
Forward P/E90.9×19.6×2nd most expensive of 13
ROIC minus cost of capital-6.0 pp-1.8 pp8th lowest of 20
Net debt / EBITDA-4.9×1.7×3rd least indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Suzhou MedicalSystem Technology 603990.SSChina$991M+28%-15%5%90.9×n/an/a
Bravura Solutions BVS.AXAustralia$996M+47%-10%25%23.7×3.7%+3.1%
Shandong Extreme Vision Technology 6636.HKHong Kong$999M-30%+14%-19%299.7×n/an/a
Playtika PLTKUnited States$983M-26%+4%19%4.0×-18.7%+3.0%
Frequentis FQT.DEGermany$981M-10%+34%9%21.3×-5.2%+14.1%
Shanghai Yaoji Technology 002605.SZChina$1.01B-17%-3%20%13.2×4.3%+1.0%
Blackbuck BLACKBUCK.NSIndia$1.01B-3%+50%14%48.8×33.2%+54.8%
Sichuan Xun You Network Technology 300467.SZChina$1.01B-25%+2%1%n/an/an/a
Tuya 2391.HKHong Kong$965M-30%+7%5%n/an/an/a
BZS (Beijing) Technology Development 603082.SSChina$1.02B-4%+22%6%n/a21.2%+13.7%
Shenzhen Sunline Tech 300348.SZChina$958M-28%+19%-1%73.5×n/an/a
74Software 74SW.PAFrance$1.03B-15%+11%14%12.7×-2.1%+18.9%
PAR Technology PARUnited States$949M+57%+17%-7%17.8×n/an/a
Kakao Games 293490.KSSouth Korea$946M+4%-21%-27%n/an/an/a
Shiprocket SHIPROCKET.NSIndia$946Mn/a+24%-5%n/a41.3%+23.0%
EverCommerce EVCMUnited States$1.06B-42%-2%13%9.1×8.1%+11.8%
Tansun Technology 300872.SZChina$925M-34%-10%-12%60.2×n/an/a
ICkey (Shanghai) Internet & Technology 301563.SZChina$1.06B-35%+26%9%n/an/an/a
Shenzhen HQVT Technology 1392.HKHong Kong$922Mn/a+28%5%n/an/an/a
Transwarp Technology (Shanghai) 6727.HKHong Kong$1.07Bn/a+32%-50%n/an/an/a
Chinasoft International 0354.HKHong Kong$1.07B-5%+3%2%11.2×16.9%+3.1%

Questions

Which companies are Suzhou MedicalSystem Technology's closest peers?
The cockpit's peer set: Bravura Solutions (BVS.AX), Shandong Extreme Vision Technology (6636.HK), Playtika (PLTK), Frequentis (FQT.DE), Shanghai Yaoji Technology (002605.SZ), Blackbuck (BLACKBUCK.NS), Sichuan Xun You Network Technology (300467.SZ), Tuya (2391.HK).
Is Suzhou MedicalSystem Technology expensive compared with its peers?
On forward p/e it trades at 90.9× against a peer median of 19.6×, 2nd most expensive of 13 in its peer set.
How has Suzhou MedicalSystem Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +28.0% against -17.3% for the median peer; over one year +27.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.